Insider · CIK 0001321466

NEUMANN CLARKE

Reports to the SEC for 2 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001321466

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-08-15	BIORA THERAPEUTICS, INC.F Tax Payment	See Remarks	FTax Payment	−26.6K sh	$0.67	−$17.8K	465,564
2024-02-15	BIORA THERAPEUTICS, INC.A Award	See Remarks	AAward	+230K sh	—	—	492,193
2023-08-15	BIORA THERAPEUTICS, INC.F Tax Payment	See Remarks	FTax Payment	−36.2K sh	$3.14	−$114K	52,018
2023-08-15	BIORA THERAPEUTICS, INC.A Award	See Remarks	AAward	+210K sh	—	—	262,193
2023-05-15	BIORA THERAPEUTICS, INC.F Tax Payment	See Remarks	FTax Payment	−2,368 sh	$3.35	−$7,932.8	88,201
2023-03-15	BIORA THERAPEUTICS, INC.A Award	See Remarks	AAward	+58K sh	—	—	79,568
2023-03-15	BIORA THERAPEUTICS, INC.A Award	See Remarks	AAward	+21.7K sh	—	—	101,252
2023-03-15	BIORA THERAPEUTICS, INC.F Tax Payment	See Remarks	FTax Payment	−10.7K sh	$2.56	−$27.3K	90,569
2023-02-15	BIORA THERAPEUTICS, INC.F Tax Payment	See Remarks	FTax Payment	−84 sh	$3.46	−$290.64	21,618
2023-01-03	BIORA THERAPEUTICS, INC.D Disposition to Issuer	See Remarks	DDisposition to Issuer	−44 sh	—	—	0
2022-11-15	BIORA THERAPEUTICS, INC.F Tax Payment	See Remarks	FTax Payment	−4,529 sh	$0.27	−$1,222.83	542,398
2022-08-15	BIORA THERAPEUTICS, INC.F Tax Payment	See Remarks	FTax Payment	−1,355 sh	$1.04	−$1,409.2	546,927
2022-05-15	BIORA THERAPEUTICS, INC.F Tax Payment	See Remarks	FTax Payment	−8,305 sh	$0.75	−$6,228.75	308,320
2022-05-15	BIORA THERAPEUTICS, INC.A Award	See Remarks	AAward	+240K sh	—	—	548,282
2022-05-15	BIORA THERAPEUTICS, INC.Stock Option (Right to Buy)A Award	See Remarks	AAward	+388K sh	—	—	387,752
2022-04-15	BIORA THERAPEUTICS, INC.A Award	See Remarks	AAward	+185K sh	—	—	316,625
2022-04-15	BIORA THERAPEUTICS, INC.Stock Option (Right to Buy)A Award	See Remarks	AAward	+299K sh	—	—	299,197
2022-02-15	BIORA THERAPEUTICS, INC.F Tax Payment	See Remarks	FTax Payment	−1,716 sh	$1.90	−$3,260.4	131,782
2021-11-15	BIORA THERAPEUTICS, INC.F Tax Payment	See Remarks	FTax Payment	−752 sh	$3.47	−$2,609.44	133,498
2021-08-15	BIORA THERAPEUTICS, INC.F Tax Payment	See Remarks	FTax Payment	−2,336 sh	$1.66	−$3,877.76	134,250
2021-05-15	BIORA THERAPEUTICS, INC.F Tax Payment	See Remarks	FTax Payment	−1,505 sh	$2.36	−$3,551.8	136,586
2021-04-15	BIORA THERAPEUTICS, INC.A Award	See Remarks	AAward	+87.4K sh	—	—	138,091
2021-04-15	BIORA THERAPEUTICS, INC.Stock Option (Right to Buy)A Award	See Remarks	AAward	+183K sh	—	—	183,265
2021-03-15	BIORA THERAPEUTICS, INC.Stock Option (Right to Buy)A Award	See Remarks	AAward	+89.1K sh	—	—	89,137
2021-03-04	BIORA THERAPEUTICS, INC.F Tax Payment	See Remarks	FTax Payment	−1,564 sh	$4.05	−$6,334.2	50,735
2021-02-15	BIORA THERAPEUTICS, INC.F Tax Payment	See Remarks	FTax Payment	−663 sh	$5.60	−$3,712.8	52,299
2020-12-19	BIORA THERAPEUTICS, INC.F Tax Payment	See Remarks	FTax Payment	−1,726 sh	$6.32	−$10.9K	52,962
2020-08-15	BIORA THERAPEUTICS, INC.A Award	See Remarks	AAward	+20.5K sh	—	—	54,688
2020-08-15	BIORA THERAPEUTICS, INC.Stock Option (Right to Buy)A Award	See Remarks	AAward	+42.1K sh	—	—	42,114
2020-03-04	BIORA THERAPEUTICS, INC.Stock Option (Right to Buy)A Award	See Remarks	AAward	+34.8K sh	—	—	34,800
2019-04-15	BIORA THERAPEUTICS, INC.Stock Option (Right to Buy)A Award	See Remarks	AAward	+19.4K sh	—	—	19,422
2018-02-22	BIORA THERAPEUTICS, INC.Stock Option (Right to Buy)A Award	See Remarks	AAward	+6,474 sh	—	—	6,474
2017-02-23	BIORA THERAPEUTICS, INC.Stock Option (Right to Buy)A Award	See Remarks	AAward	+19.4K sh	—	—	19,423
2012-02-07	SEQUENOM INCA Award	VP & General Counsel	AAward	+933 sh	—	—	19,617
2012-02-07	SEQUENOM INCF Tax Payment	VP & General Counsel	FTax Payment	−390 sh	$4.92	−$1,918.8	19,227
2012-02-07	SEQUENOM INCA Award	VP & General Counsel	AAward	+933 sh	—	—	20,160
2012-02-07	SEQUENOM INCF Tax Payment	VP & General Counsel	FTax Payment	−390 sh	$4.92	−$1,918.8	19,770
2012-02-07	SEQUENOM INCA Award	VP & General Counsel	AAward	+235 sh	—	—	20,005
2012-02-07	SEQUENOM INCF Tax Payment	VP & General Counsel	FTax Payment	−98 sh	$4.92	−$482.16	19,907
2012-02-07	SEQUENOM INCIncentive Stock Option (right to buy)A Award	VP & General Counsel	AAward	+17.6K sh	—	—	17,640
2012-02-07	SEQUENOM INCNon-Qualified Stock Option (right to buy)A Award	VP & General Counsel	AAward	+25.4K sh	—	—	25,360
2011-07-18	SEQUENOM INCA Award	VP & General Counsel	AAward	+1,166 sh	—	—	19,111
2011-07-18	SEQUENOM INCF Tax Payment	VP & General Counsel	FTax Payment	−427 sh	$7.46	−$3,185.42	18,684
2011-05-09	SEQUENOM INCM Exercise/Conversion	VP & General Counsel	MExercise/Conversion	+5,000 sh	$1.87	+$9,350	22,945
2011-05-09	SEQUENOM INCS Sale	VP & General Counsel	SSale	−5,000 sh	$8.00	−$40K	17,945
2011-05-09	SEQUENOM INCM Exercise/Conversion	VP & General Counsel	MExercise/Conversion	+911 sh	$4.23	+$3,853.53	18,856
2011-05-09	SEQUENOM INCS Sale	VP & General Counsel	SSale	−911 sh	$8.00	−$7,288	17,945
2011-05-09	SEQUENOM INCM Exercise/Conversion	VP & General Counsel	MExercise/Conversion	+100 sh	$4.23	+$423	18,045
2011-05-09	SEQUENOM INCS Sale	VP & General Counsel	SSale	−100 sh	$8.00	−$800	17,945
2011-05-09	SEQUENOM INCM Exercise/Conversion	VP & General Counsel	MExercise/Conversion	+100 sh	$4.23	+$423	18,045

Recent filings

Accepted (ET)
Aug 164
NEUMANN CLARKE0000950170-24-098050
SEC(opens sec.gov)
Feb 154
NEUMANN CLARKE0000950170-24-015859
SEC(opens sec.gov)
Aug 174
NEUMANN CLARKE0000950170-23-043230
SEC(opens sec.gov)
May 174
NEUMANN CLARKE0000950170-23-022772
SEC(opens sec.gov)
Mar 174
NEUMANN CLARKE0000899243-23-009036
SEC(opens sec.gov)
Feb 174
NEUMANN CLARKE0000899243-23-005464
SEC(opens sec.gov)
Jan 54
NEUMANN CLARKE0000899243-23-000965
SEC(opens sec.gov)
Nov 164
NEUMANN CLARKE0000899243-22-036079
SEC(opens sec.gov)
Aug 164
NEUMANN CLARKE0000899243-22-028841
SEC(opens sec.gov)
May 174
NEUMANN CLARKE0000899243-22-018432
SEC(opens sec.gov)
Apr 194
NEUMANN CLARKE0000899243-22-015060
SEC(opens sec.gov)
Feb 174
NEUMANN CLARKE0000899243-22-006783
SEC(opens sec.gov)
Nov 174
NEUMANN CLARKE0000899243-21-045047
SEC(opens sec.gov)
Aug 174
NEUMANN CLARKE0000899243-21-033256
SEC(opens sec.gov)

Companies

Address

3595 JOHN HOPKINS COURT

SAN DIEGO, CA, 92121